Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$7.99 - $10.75 $3.18 Million - $4.28 Million
397,770 Added 32.88%
1,607,650 $13.8 Million
Q2 2022

Aug 15, 2022

BUY
$4.58 - $17.13 $5.54 Million - $20.7 Million
1,209,880 New
1,209,880 $10 Million

Others Institutions Holding KZR

About Kezar Life Sciences, Inc.


  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $423M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Health Cor Management, L.P. Portfolio

Follow Health Cor Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Health Cor Management, L.P. with notifications on news.